hwk-016
·Code: HWK-016
hwk-016: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | Phase 1 |
Clinical Trials (1)
A Phase 1 First-in-Human Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Frequently asked questions
Who is developing hwk-016?
hwk-016 is being developed by Whitehawk Therapeutics, Inc..
How many clinical trials involve hwk-016?
BioSniper tracks 1 clinical trial involving hwk-016.
Get deeper analysis on hwk-016
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis